Patients with severe COVID-19 have marked reductions in the number of CD4 T cells, CD8 T cells, B cells, and natural killer cells, often accompanied by exhausted T cells that exhibit diminished proliferative capacity and over-production of pro-inflammatory cytokines [307]. The gene discussed is CD8A; the disease is COVID-19.